Option chain shows key data for Hemostemix's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Hemostemix.

Hemostemix (OTC:HMTXF) Stock, Option Chain

Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.

Biotech

Cannabis

News

Penny Stocks

Emerging Markets

Markets

General

ACOGF

BABYF

EMMA

HMTXF

JNHMF

MCURF

RDHL

RLFTF

RSLS

RSPI

SLRX

VNRX

TSXV:ACOG

TSXV:HEM

TSXV:BABY

Photo by Chris Montgomery on Unsplash

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday

Hemostemix Inc

Press Releases

Hemostemix Announces Strategic Manufacturing Partnership with CytoImmune Therapeutics and $1,800,000 in Financing Commitments

Financing & Partnership News Send Shares of this Stem-Cell Therapy Company on a Tear

Life Sciences Investor Forum Agenda Announced for March 13th

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

Comments

Hemostemix

Hemostemix (HMTXF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell